Blood test could predict Cancer's return
NCT ID NCT04925089
Summary
This study aims to find better ways to predict if chemotherapy is working for patients with a type of cancer called leiomyosarcoma. Researchers will test blood samples for tiny pieces of cancer DNA and analyze detailed scans to see if these can tell doctors early on which patients are responding to treatment and which are at risk of the cancer coming back. The goal is to gather information that could help guide future treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55901, United States
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-••••
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.